Michael Rudenko MD, PhD

Prof Rudenko has significant research background in allergy and asthma. His MD PhD projects were on sub-lingual specific immunotherapy in children, adolescents and adults; he did many studies in asthma, allergy, medical mycology and immunology of herpes viruses and large number of Phase 2-3 trials as sub/co-investigator, principal investigator. He obtained 2 patents for his work in developing new schemes of treatment of recurrent herpes virus infection and prevention of CMV and EBV infection. Prof Rudenko is a Member of American Academy of Allergy Asthma and Immunology AAAAI where he served as a board member on Allergen Standardization and Allergy Diagnostics Committee as well as Practice Management Committee and an individual member of FOCIS Federation of Clinical Immunology Societies.